Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: vestor who wrote (1372)	8/4/1999 10:32:00 AM
From: Doug Bean	Respond to of 1837

Vestor: I will try to take in the whole CC And will report my impressions CRDoug

To: vestor who wrote (1372)	8/4/1999 10:34:00 AM
From: vestor	Read Replies (1) \| Respond to of 1837

The Qtrly is out. DRMD has 10.9 mil of sales that were not booked in the 2nd qtr. but will be booked in the 3rd. qtr. DRMD says it expects the BC pill to be approved this qtr. they note that there is no other generic manufacturer. The numbers are negative this qtr.I expected the Cenestin $ to be present in this qtr. However its a boost to the 3rd. qtr. They say the other new drugs that were given recent approval had ramp-up costs but will be selling in the 3rd. qtr. The 3rd. and 4th qtr. look very promising especially if the bc pill is approved.